. La-pré-Éclampsie-est-sévère-chez, 8% (n=23) des cas ayant des ?-HCG > 0,5 MoM contre 33, 3% (n=1) des cas ayant des ?-HCG ? 0,5 MoM. La différence n'est pas statistiquement significative, p.5915

M. Overgaard, J. Haaning, H. Boldt, I. Olsen, L. Laursen et al., Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor, Journal of Biological Chemistry, vol.327, issue.40, pp.31128-31161, 2000.
DOI : 10.1073/pnas.87.1.364

A. Fowden, The Insulin-like Growth Factors and feto-placental Growth, Placenta, vol.24, issue.8-9, pp.803-815, 2003.
DOI : 10.1016/S0143-4004(03)00080-8

A. Gagnon, R. Wilson, F. Audibert, V. Allen, C. Blight et al., Obstetrical Complications Associated With Abnormal Maternal Serum Markers Analytes, Journal of Obstetrics and Gynaecology Canada, vol.30, issue.10, pp.918-950, 2008.
DOI : 10.1016/S1701-2163(16)32973-5

E. Abalos, C. Cuesta, A. Grosso, D. Chou, and L. Say, Global and regional estimates of preeclampsia and eclampsia: a systematic review, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.170, issue.1, pp.1-7, 2013.
DOI : 10.1016/j.ejogrb.2013.05.005

E. Abalos, C. Cuesta, G. Carroli, Z. Qureshi, M. Widmer et al., Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health, BJOG: An International Journal of Obstetrics & Gynaecology, vol.120, pp.14-24, 2014.
DOI : 10.1111/j.1471-0528.2012.03496.x

C. Sfar, S. , and S. , Prise en charge multidisciplinaire des formes graves de la pré-éclampsie, 2009.

E. Clouqueur, D. Subtil, G. Robin, and V. Tsatsaris, Que reste-il des indications de l'aspirine en cours de grossesse ?, 2010.

C. Geyl, D. Subtil, P. Vaast, C. Coulon, E. Clouqueur et al., Interpr??tation des valeurs atypiques des marqueurs s??riques, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.1, pp.5-11, 2014.
DOI : 10.1016/j.jgyn.2013.08.013

K. Spencer, N. Cowans, and K. Nicolaides, Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia, Prenatal Diagnosis, vol.15, issue.1, pp.7-10, 2008.
DOI : 10.1111/j.1471-0528.2000.tb11618.x

Y. Yaron, S. Heifetz, Y. Ochshorn, O. Lehavi, and A. Orr-urtreger, Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome, Prenatal Diagnosis, vol.106, issue.9, pp.778-82, 2002.
DOI : 10.1111/j.1471-0528.1999.tb08405.x

F. Muller, S. Dreux, I. Czerkiewicz, M. Bernard, J. Guibourdenche et al., D??pistage de la trisomie 21??par les marqueurs s??riques maternels??: justification des commentaires appliqu??s par les biologistes, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.9, pp.671-680, 2014.
DOI : 10.1016/j.jgyn.2014.05.012

K. Duckitt and D. Harrington, Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies, BMJ, vol.330, issue.7491, p.565, 2005.
DOI : 10.1136/bmj.38380.674340.E0

P. Merviel, L. Touzart, V. Deslandes, M. Delmas, M. Coicaud et al., Facteurs de risque de la pr????clampsie en cas de grossesse unique, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.37, issue.5, pp.477-82, 2008.
DOI : 10.1016/j.jgyn.2008.04.001

D. Wright, A. Syngelaki, R. Akolekar, L. Poon, and K. Nicolaides, Competing risks model in screening for preeclampsia by maternal characteristics and medical history, American Journal of Obstetrics and Gynecology, vol.213, issue.1, pp.62-63, 2015.
DOI : 10.1016/j.ajog.2015.02.018

K. Goetzinger, M. Tuuli, A. Cahill, G. Macones, and A. Odibo, 715: Development and validation of a risk factor scoring system for first-trimester prediction of pre-eclampsia, American Journal of Obstetrics and Gynecology, vol.208, issue.1, pp.1049-56, 2014.
DOI : 10.1016/j.ajog.2012.10.053

O. Gorman, N. Wright, D. Syngelaki, A. Akolekar, R. Wright et al., Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation, Am J Obstet Gynecol. janv, vol.214, issue.1, pp.103-104, 2016.

R. Morris, A. Bilagi, P. Devani, and M. Kilby, Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis, Prenatal Diagnosis, vol.10, issue.2, pp.253-65, 2017.
DOI : 10.1371/journal.pmed.1001381

L. Dugoff, J. Hobbins, F. Malone, T. Porter, D. Luthy et al., First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial), American Journal of Obstetrics and Gynecology, vol.191, issue.4, pp.1446-51, 2004.
DOI : 10.1016/j.ajog.2004.06.052

C. Ong, A. Liao, K. Spencer, S. Munim, and K. Nicolaides, First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications, BJOG: An International Journal of Obstetrics and Gynaecology, vol.93, issue.10, pp.1265-70, 2000.
DOI : 10.1002/(SICI)1097-0223(199802)18:2<147::AID-PD231>3.0.CO;2-W

K. Spencer, C. Yu, N. Cowans, C. Otigbah, and K. Nicolaides, Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free ??-hCG and with second-trimester uterine artery Doppler, Prenatal Diagnosis, vol.15, issue.10, pp.949-53, 2005.
DOI : 10.1111/j.1471-0528.2000.tb13343.x

H. Park, S. Shim, and D. Cha, Combined Screening for Early Detection of Pre-Eclampsia, International Journal of Molecular Sciences, vol.34, issue.8
DOI : 10.3892/mmr.2014.3118